PharmaBoardroom

The latest news from French healthcare and pharma, including an update on the hospital crisis; MaaT Pharma and Skyepharma's new cGMP microbiome…

Amgen has forged a solid position as one of the world’s largest independent biotechnology companies. With a market capitalisation of some USD 130…

The European Coalition for Access to Comprehensive Genomic Profiling (ECGP) is a new initiative made up of industry association the European…

Following the COVID-19 pandemic and the resulting supply chain disruptions, global drug pricing and access reforms have multiplied. The Inflation…

The latest news from UK healthcare and life sciences, including the safety review of Novo Nordisk's GLP-1 receptor agonists; VaxEquity's grant to…

Rainer Westermann, chairman of the Life Sciences Acceleration Alliance e.V. (LSAA), which lobbies on behalf of European venture capitalists in the…

In the French government's recent cabinet reshuffle, prime minister Elisabeth Borne’s former chief of staff, Aurélien Rousseau was appointed as the…

Perhaps to the surprise of many, Belgium is the world’s second-largest producer of vaccines, behind only the US, and – capitalising on its years…

Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously…

Paul Tam, who serves as chair professor & VP at Macau University of Science and Technology as well as emeritus professor and honorary clinical…

The latest from Mexican pharma, including the distribution agreement between Dow and Azelis, Neuraxpharm's new LatAm subsidiaries in Mexico and…

Belgian healthcare performs strongly across most metrics and international comparisons, but – as elsewhere – there remains room for improvement in…